saxagliptine sandoz 2,5 mg, comprimé pelliculé
sandoz - saxagliptine - comprimé - 2,5 mg - composition pour un comprimé > saxagliptine : 2,5 mg . sous forme de : chlorhydrate de saxagliptine - médicaments utilisés dans le diabète. inhibiteurs de la dipeptidyl peptidase 4 (dpp-4)
saxagliptine sandoz 5 mg, comprimé pelliculé
sandoz - saxagliptine - comprimé - 5 mg - composition pour un comprimé > saxagliptine : 5 mg . sous forme de : chlorhydrate de saxagliptine - médicaments utilisés dans le diabète. inhibiteurs de la dipeptidyl peptidase 4 (dpp-4)
onglyza
astrazeneca ab - la saxagliptine - diabète sucré, type 2 - les médicaments utilisés dans le diabète - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.
saxagliptin sandoz 2,5 mg compr. pellic.
sandoz sa-nv - chlorhydrate de saxagliptine 2,789 mg - eq. saxagliptine 2,5 mg - comprimé pelliculé - 2,5 mg - chlorhydrate de saxagliptine 2.789 mg - saxagliptin
saxagliptin sandoz 5 mg compr. pellic.
sandoz sa-nv - chlorhydrate de saxagliptine 5,578 mg - eq. saxagliptine 5 mg - comprimé pelliculé - 5 mg - chlorhydrate de saxagliptine 5.578 mg - saxagliptin
onglyza 2.5 mg comprimés pelliculés
astrazeneca ag - saxagliptinum - comprimés pelliculés - saxagliptinum 2.5 mg ut saxagliptini hydrochloridum, lactosum monohydricum 99.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.95 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, e 171, talcum, e 172 (flavum), acidum hydrochloridum, drucktinte: e 132, lacca, pro compresso obducto. - antidiabetikum - synthetika
onglyza 5 mg comprimés pelliculés
astrazeneca ag - saxagliptinum - comprimés pelliculés - saxagliptinum 5.0 mg ut saxagliptini hydrochloridum, lactosum monohydricum 99.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.95 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (rubrum), acidum hydrochloridum, drucktinte: e 132, lacca, pro compresso obducto. - antidiabetikum - synthetika
onglyza comprimé
astrazeneca canada inc - saxagliptine (chlorhydrate de saxagliptine) - comprimé - 5mg - saxagliptine (chlorhydrate de saxagliptine) 5mg - dipeptidyl peptidase-4 (dpp-4) inhibitors
onglyza comprimé
astrazeneca canada inc - saxagliptine (chlorhydrate de saxagliptine) - comprimé - 2.5mg - saxagliptine (chlorhydrate de saxagliptine) 2.5mg - dipeptidyl peptidase-4 (dpp-4) inhibitors
sandoz saxagliptin comprimé
sandoz canada incorporated - saxagliptine (chlorhydrate de saxagliptine) - comprimé - 2.5mg - saxagliptine (chlorhydrate de saxagliptine) 2.5mg - dipeptidyl peptidase-4 (dpp-4) inhibitors